BioPharma Product Testing Guide

Eurofins BioPharma Product Testing operates the world’s largest network of harmonized GMP laboratories, spanning 46 facilities across 20+ countries. With over 60 years of experience, Eurofins delivers an unmatched breadth of biopharmaceutical testing services, supporting every stage of drug development—from starting materials to finished product, and from preclinical through post-commercialization. Their global infrastructure includes over 400 stability chambers, advanced microbiology modules, and state-of-the-art laboratories for biochemistry, chemistry, cell biology, and virology.

Eurofins’ comprehensive service portfolio encompasses method development and validation, stability testing, microbial testing, environmental monitoring, viral safety, extractables and leachables testing, and more. They offer flexible delivery models including Fee-for-Service, Full-Time Equivalent (FTE), and PSS® Insourcing Solutions, allowing clients to tailor services to their operational needs. Their proprietary systems—eLIMS-BPT, Electronic Laboratory Notebooks (ELN), and LabAccessSM—ensure streamlined, secure, and harmonized data handling across all locations.

By adhering to a unified Global Quality Policy Manual and maintaining compliance with international regulatory standards (FDA, EMA, JP, etc.), Eurofins ensures data integrity and global regulatory acceptance. Their harmonized methodologies, innovative IT infrastructure, and experienced scientific teams support efficient project execution with consistent quality.

Eurofins is positioned as the premier partner for biopharma companies seeking high-quality, scalable, and compliant testing services to bring products to market faster and with confidence.